Henry O Gosebruch is a director of Acelyrin Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Feb 24 | NMRA Neumora Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 80,000 | 0.00 | 462,345 |
14 Feb 24 | NMRA Neumora Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 18.07 | 160,000 | 2.89 mm | 160,000 |
19 Sep 23 | NMRA Neumora Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 12.6247 | 15,000 | 189.37 k | 15,000 |
9 May 23 | SLRN Acelyrin | Common Stock | Buy | Acquire P | No | No | 18 | 50,000 | 900.00 k | 50,000 |
9 May 23 | SLRN Acelyrin | Director Stock Option Common Stock | Other | Acquire J | No | No | 7.4345 | 155,450 | 1.16 mm | 155,450 |
9 May 23 | SLRN Acelyrin | Director Stock Option Class A Common Stock | Other | Dispose J | No | No | 7.4345 | 155,450 | 1.16 mm | 0 |